Recruiting studies
Idiopathic Pulmonary Fibrosis
Study
Idiopathic pulmonary fibrosis – A preventive approach
About the study commissioned by Diex Recherche:
Idiopathic pulmonary fibrosis is a progressive lung disease that causes scarring of the tissues in the lungs, gradually reducing their ability to function effectively. Acting early is essential to slow its impact.
Although there is no cure, our study explores the effectiveness of an innovative drug to slow the progression of the disease and promote a better quality of life.
By joining our study, you may see an improvement in your breathing capacity, a reduction in persistent cough, and a reduction in fatigue related to this condition.
Why participate?
Contribute to medical research: Your participation can help develop an innovative treatment for idiopathic pulmonary fibrosis.
Access to specialized care: Close monitoring by an experienced medical team and free examinations linked to the study.
Financial compensation: Compensation is offered for your time and travel, if you meet the eligibility criteria.
Who is eligible?
We invite to participate individuals who:
- Are aged 40 and over
- Have a confirmed diagnosis of idiopathic pulmonary fibrosis for at least 7 years
How does it work?
Pre-registration: Start by completing our online pre-registration form to help us determine if you may be eligible.
Initial Assessment: If you are considered pre-eligible, an invitation will be sent to you to come to our center for a detailed assessment.
Participation: After confirmation of your eligibility, you will receive all the information required to begin your participation in this study.
I want to apply to this clinical study
For more information, contact us at 819 801-9797 (Trois-Rivières) or at 1-844-739-3439 (toll free), or fill the online form.
The study process in pictures
Explanation
Step 1 | Before starting the study, we will take time to fully explain the selection process and the conduct of the study by phone.
Meeting
Step 2 | After the initial phone interview, if you are still interested in taking part in a study, we schedule a preliminary meeting with you during which you may ask all the questions you wish and take the time you require to read over the consent form. This form explains, in detail, the different stages of each study.
Decision
Step 3 | You may make a decision at that time to move forward with or terminate the selection process. However, you are under no obligation to make an immediate decision. Based on briefing content, you may take the time necessary to come to a decision and consult with your personal physician or loved ones.
Tests
Step 4 | Depending on the nature of the study, some tests or medical examinations may be required. In the majority of cases, these tests or examinations are conducted on Diex Research premises based on your individual availability.
Departure
Step 5 | If you are eligible, you may then begin a clinical study with us.
